Eustachian tube dysfunction often determines whether a routine ear infection clears quickly or develops into a persistent ...

KJ was born with a deficiency in an enzyme that breaks down ammonia, a by-product of protein digestion. He had to follow a ...

Subject to TSX Venture Exchange (“ TSXV ”) approval, NurExone has engaged Russo Partners LLC, a New York–based strategic ...

NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) ("NurExone" or the "Company"), a preclinical-biotechnology ...

Put the pieces together and you can see a plausible near-future where human scientists focus more on choosing good questions and interpreting results, while an invisible layer of AI systems handles ...

Deployment addresses the $1 billion antibody-reproducibility crisis by enabling rapid, objective validation of research ...

Drug discovery is a high-risk, high-cost endeavor, with over 90% of candidates failing in clinical development. A significant proportion of these failures stem from unresolved biopharmaceutic ...

Drug discovery is a high-risk, high-cost endeavor, with over 90% of candidates failing in clinical development. A significant proportion of these ...

Discusses SCOPE Phase II Data: iSCIB1+ Shows Improved Progression-Free Survival in Advanced Melanoma December 11, 2025 9:00 ...

Candidates preparing for JEE Advanced 2026 can download the official syllabus PDF from jeeadv.ac.in, released by IIT Roorkee.

The study introduces a three-circle convergence framework, AI, smart functionality and sustainability, demonstrating that the ...

Scientists have identified a small flaw in the enzyme GPX4 that prevents neurons from defending themselves. This mutation, ...